285 related articles for article (PubMed ID: 29200162)
21. [Prognostic Value of Recurrent Molecular Genetics and Epigenetics Abnormity in T Lymphoblastic Lymphoma / Leukemia -Review].
Guan W; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):587-591. PubMed ID: 28446316
[TBL] [Abstract][Full Text] [Related]
22. The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.
Kox C; Zimmermann M; Stanulla M; Leible S; Schrappe M; Ludwig WD; Koehler R; Tolle G; Bandapalli OR; Breit S; Muckenthaler MU; Kulozik AE
Leukemia; 2010 Dec; 24(12):2005-13. PubMed ID: 20944675
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel NOTCH1 mutations: increasing our knowledge of the NOTCH signaling pathway.
Gallo Llorente L; Luther H; Schneppenheim R; Zimmermann M; Felice M; Horstmann MA
Pediatr Blood Cancer; 2014 May; 61(5):788-96. PubMed ID: 24249312
[TBL] [Abstract][Full Text] [Related]
24. Targeted sequencing to identify genetic alterations and prognostic markers in pediatric T-cell acute lymphoblastic leukemia.
Chang YH; Yu CH; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Chang HH; Lin DT; Lin SW; Chen HY; Yang YL
Sci Rep; 2021 Jan; 11(1):769. PubMed ID: 33436855
[TBL] [Abstract][Full Text] [Related]
25. Gene mutation profiles and prognostic implications in Korean patients with T-lymphoblastic leukemia.
Huh HJ; Lee SH; Yoo KH; Sung KW; Koo HH; Jang JH; Kim K; Kim SJ; Kim WS; Jung CW; Lee KO; Kim SH; Kim HJ
Ann Hematol; 2013 May; 92(5):635-44. PubMed ID: 23354995
[TBL] [Abstract][Full Text] [Related]
26. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
Callens C; Baleydier F; Lengline E; Ben Abdelali R; Petit A; Villarese P; Cieslak A; Minard-Colin V; Rullier A; Moreau A; Baruchel A; Schmitt C; Asnafi V; Bertrand Y; Macintyre E
J Clin Oncol; 2012 Jun; 30(16):1966-73. PubMed ID: 22547598
[TBL] [Abstract][Full Text] [Related]
27. [The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients].
Fang QY; Hao QS; Gong XY; Wang J; Li QH; Yuan T; Tian Z; Liu KQ; Li Y; Liu YT; Gong BF; Wang Y; Wei H; Zhou CL; Lin D; Liu BC; Wei SN; Zhang GJ; Wang JX; Mi YC
Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):432-435. PubMed ID: 34218589
[No Abstract] [Full Text] [Related]
28. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.
Wang Q; Qiu H; Jiang H; Wu L; Dong S; Pan J; Wang W; Ping N; Xia J; Sun A; Wu D; Xue Y; Drexler HG; Macleod RA; Chen S
Haematologica; 2011 Dec; 96(12):1808-14. PubMed ID: 21880637
[TBL] [Abstract][Full Text] [Related]
29. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas.
Jen KY; Song IY; Banta KL; Wu D; Mao JH; Balmain A
Blood; 2012 Jan; 119(3):805-9. PubMed ID: 22117044
[TBL] [Abstract][Full Text] [Related]
30. NOTCH1 mutations are associated with favourable long-term prognosis in paediatric T-cell acute lymphoblastic leukaemia: a retrospective study of patients treated on BCH-2003 and CCLG-2008 protocol in China.
Gao C; Liu SG; Zhang RD; Li WJ; Zhao XX; Cui L; Wu MY; Zheng HY; Li ZG
Br J Haematol; 2014 Jul; 166(2):221-8. PubMed ID: 24690100
[TBL] [Abstract][Full Text] [Related]
31. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951.
Clappier E; Collette S; Grardel N; Girard S; Suarez L; Brunie G; Kaltenbach S; Yakouben K; Mazingue F; Robert A; Boutard P; Plantaz D; Rohrlich P; van Vlierberghe P; Preudhomme C; Otten J; Speleman F; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
Leukemia; 2010 Dec; 24(12):2023-31. PubMed ID: 20861920
[TBL] [Abstract][Full Text] [Related]
32.
Close V; Close W; Kugler SJ; Reichenzeller M; Yosifov DY; Bloehdorn J; Pan L; Tausch E; Westhoff MA; Döhner H; Stilgenbauer S; Oswald F; Mertens D
Blood; 2019 Feb; 133(8):830-839. PubMed ID: 30510140
[No Abstract] [Full Text] [Related]
33. Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
Jenkinson S; Kirkwood AA; Goulden N; Vora A; Linch DC; Gale RE
Leukemia; 2016 Jan; 30(1):39-47. PubMed ID: 26220040
[TBL] [Abstract][Full Text] [Related]
34. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.
Zuurbier L; Petricoin EF; Vuerhard MJ; Calvert V; Kooi C; Buijs-Gladdines JG; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Pieters R; Meijerink JP
Haematologica; 2012 Sep; 97(9):1405-13. PubMed ID: 22491738
[TBL] [Abstract][Full Text] [Related]
35. Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.
Ben Abdelali R; Asnafi V; Leguay T; Boissel N; Buzyn A; Chevallier P; Thomas X; Lepretre S; Huguet F; Vey N; Escoffre-Barbe M; Tavernier E; Reman O; Fegueux N; Turlure P; Rousselot P; Cahn JY; Lheritier V; Chalandon Y; Béné MC; Macintyre E; Dombret H; Ifrah N;
Blood; 2011 Nov; 118(19):5099-107. PubMed ID: 21835957
[TBL] [Abstract][Full Text] [Related]
36. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
[TBL] [Abstract][Full Text] [Related]
37. NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.
Bandapalli OR; Zimmermann M; Kox C; Stanulla M; Schrappe M; Ludwig WD; Koehler R; Muckenthaler MU; Kulozik AE
Haematologica; 2013 Jun; 98(6):928-36. PubMed ID: 23349303
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.
Yeh CH; Bellon M; Pancewicz-Wojtkiewicz J; Nicot C
Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6731-6. PubMed ID: 27247421
[TBL] [Abstract][Full Text] [Related]
39. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.
Feng J; Li Y; Jia Y; Fang Q; Gong X; Dong X; Ru K; Li Q; Zhao X; Liu K; Wang M; Tian Z; Jia Y; Wang Y; Lin D; Wei H; Tang K; Mi Y; Wang J
J Hematol Oncol; 2017 Feb; 10(1):61. PubMed ID: 28245838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
